Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

NCT06891196 | Active Not Recruiting

• 1 other identifier: 24-012155
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

This study, titled "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," aims to assess the long-term effectiveness of treatments for pediatric hip conditions, including hip dysplasia, Legg-Calve-Perthes disease, SCFE, and avascular necrosis.

Conditions

Hip Dysplasia; Legg-Calvâe-Perthes Disease; Avascular Necrosis of Hip

Outcome Measures

Primary Outcomes (1)

• Revision surgery

  Total number of patients who required revision surgery for pediatric hip conditions

  2 years

Secondary Outcomes (3)

• Change in neck-shaft angle measurement

  Baseline, 2 years

• Change in acetabular index

  Baseline, 2 years

• Change in migration index

  Baseline, 2 years

Study Arms (1)

Pediatric patients with hip conditions

Medical records and radiographs of patients who were treated for hip conditions at Mayo Clinic from 1975 to 2022 will be included in a retrospective chart review. Radiographic evaluations will include measurements of the neck-shaft angle, acetabular index, migration index, and other commonly used metrics. The prospective follow-up will include a subset of patients from the retrospective review, who will be complete long-term follow-up surveys.

Other: Long-term Follow-up Surveys

Interventions

Long-term Follow-up Surveys OTHER

Patients will be given surveys, including validated PRO measures such as the Hip Disability and Osteoarthritis Outcomes Score (HOOS), Short-Form 12 (SF-12), Visual Analog Scale (VAS) for pain, and Marx activity scores.

Pediatric patients with hip conditions

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024.

You may qualify if:

• Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024
• Patients over 18 who can be contacted for follow-up and are willing to participate.

You may not qualify if:

• Patients presenting over age 18 for hip dysplasia
• Patients who are unwilling to complete follow up surveys.

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Hip Dislocation

Condition Hierarchy (Ancestors)

Joint Dislocations; Joint Diseases; Musculoskeletal Diseases; Wounds and Injuries; Hip Injuries

Study Officials

• Emmanouil Grigoriou, M.D.

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: February 19, 2025
• First Posted: March 24, 2025
• Study Start: January 15, 2025
• Primary Completion: January 15, 2026
• Study Completion: January 15, 2026
• Last Updated: March 24, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)